- Earnshaw, WC;
- Allshire, RC;
- Black, BE;
- Bloom, K;
- Brinkley, BR;
- Brown, W;
- Cheeseman, IM;
- Choo, KHA;
- Copenhaver, GP;
- Deluca, JG;
- Desai, A;
- Diekmann, S;
- Erhardt, S;
- Fitzgerald-Hayes, M;
- Foltz, D;
- Fukagawa, T;
- Gassmann, R;
- Gerlich, DW;
- Glover, DM;
- Gorbsky, GJ;
- Harrison, SC;
- Heun, P;
- Hirota, T;
- Jansen, LET;
- Karpen, G;
- Kops, GJPL;
- Lampson, MA;
- Lens, SM;
- Losada, A;
- Luger, K;
- Maiato, H;
- Maddox, PS;
- Margolis, RL;
- Masumoto, H;
- McAinsh, AD;
- Mellone, BG;
- Meraldi, P;
- Musacchio, A;
- Oegema, K;
- O'Neill, RJ;
- Salmon, ED;
- Scott, KC;
- Straight, AF;
- Stukenberg, PT;
- Sullivan, BA;
- Sullivan, KF;
- Sunkel, CE;
- Swedlow, JR;
- Walczak, CE;
- Warburton, PE;
- Westermann, S;
- Willard, HF;
- Wordeman, L;
- Yanagida, M;
- Yen, TJ;
- Yoda, K;
- Cleveland, DW
The first centromeric protein identified in any species was CENP-A, a divergent member of the histone H3 family that was recognised by autoantibodies from patients with scleroderma-spectrum disease. It has recently been suggested to rename this protein CenH3. Here, we argue that the original name should be maintained both because it is the basis of a long established nomenclature for centromere proteins and because it avoids confusion due to the presence of canonical histone H3 at centromeres.